Symptomatic intestinal strictures develop in more than one third of patients with Crohn’s
disease (CD) within 10 years of disease onset. Strictures can be inflammatory, fibrotic or mixed …

The past decade has brought substantial advances in the management of inflammatory bowel
diseases (IBD). The introduction of tumor necrosis factor (TNF) antagonists, evidence for …

Important deteriorations in body composition and strength occur and need to be accurately
measured in advanced cancer patients (ACPs). The aim of this study was to establish the …

Lymphangiomatosis is a rare and fatal congenital lymphatic malformation. Because the natural
course of the disease affects multiple body systems, the management can be challenging…

Background Half of patients with inflammatory bowel disease (IBD) require hospitalization.
We sought to characterize inpatient quality indicators of care and outcomes during IBD-…

Background. Treatment options are limited for patients with refractory cirrhotic ascites (RCA).
As such, we assessed the safety and effectiveness of the PleurX catheter for RCA. Methods. …

Background Crohn disease (CD) and ulcerative colitis (UC) have high health care
expenditures because of medications, hospitalizations, and surgeries. We evaluated disease …

Cardiorenal syndrome is a complex condition, which requires the collaboration and resources
from cardiology, cardiac surgery, nephrology, and critical care. Of great importance is …

Background Patients with Crohn’s disease [CD] and ulcerative colitis [UC] are at increased
risk for colorectal dysplasia [CRD] and colorectal cancer [CRC]. Adherence to CRC …

Background Evaluating clinical data on the safety and efficacy of vedolizumab (VDZ) in ‘real-world’
setting is still desirable. Recent reports have raised concerns that arthralgia may be …